Holmström, Ulrika
Tsitsopoulos, Parmenion P.
Holtz, Anders
Salci, Konstantin
Shaw, Gerry
Mondello, Stefania
Marklund, Niklas
Funding for this research was provided by:
Uppsala Universitet
Svenska Forskningsrådet Formas (None)
Article History
Received: 20 November 2019
Accepted: 4 April 2020
First Online: 25 June 2020
Compliance with ethical standards
:
: Dr. Shaw is the founder and CEO of EnCor Biotechnology, Inc., Gainesville, FL, USA. The remaining authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers’ bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent-licensing arrangements), or non-financial interest (such as personal or professional relationships, affiliations, knowledge, or beliefs) in the subject matter or materials discussed in this manuscript.
: The prospective study was approved by the local ethics committee of Uppsala University Hospital (400/2012). All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the ethical standards of the Helsinki Declaration of 1975, as revised in 2008. All recruited patients signed a written informed consent form prior to study inclusion.